Lakefront Biotherapeutics · EURONEXT:LKFT
Lakefront Biotherapeutics shareholders
As of Jun 30, 2026, 77 institutions reported holding Lakefront Biotherapeutics. Largest: Gilead Sciences, Inc., Tang Capital Management LLC and Madison Avenue Partners, LP. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Lakefront Biotherapeutics | Change | Filed |
|---|---|---|---|---|
| Gilead Sciences, Inc. | 16.7M | no change | Aug 3, 2026 | |
| Tang Capital Management LLC | 3.79M | no change | Aug 14, 2026 | |
| Madison Avenue Partners, LP | 3.45M | +983K | Aug 14, 2026 | |
| Prosight Management, LP | 2.04M | +493K | Aug 14, 2026 | |
| EcoR1 Capital, LLC | 1.67M | no change | Aug 14, 2026 | |
| Ameriprise | 1.27M | −152K | Aug 14, 2026 | |
| DME Capital Management, LP | 483K | no change | Aug 14, 2026 | |
| Renaissance Technologies | 408K | +92,400 | Aug 13, 2026 | |
| BlackRock | 338K | +26,046 | Aug 7, 2026 | |
| Point72 Asset Management, L.P. | 270K | −62,311 | Aug 14, 2026 |